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Abstract
Background: Available scientific data related to cardiac 
troponin I (cTnI) release after intermittent exercise is 
limited. It is also of interest to determine what personal 
or environmental factors mediate the exercise-induced 
release of cTnI. This study had two objectives: 1) to 
examine the individual release of cTnI to a basketball 
match; and 2) to establish the influence of athlete status 
as well as biological age on cTnI release.
Methods: Thirty-six basketball players (12 adult elite 
[PBA]: 27.3±4.1 years, 12 adult amateur [ABA]: 29.6±2.9 
years, and 12 junior elite [JBA]: 16.6±0.9 years) partici-
pated in a simulated basketball match with serial assess-
ment of cTnI at rest, immediately post- and at 1, 3, 6, 12, 
and 24 h post-exercise.
Results: The basketball match increased cTnI levels (pre: 
median [range]; 0.006 [0.001–0.026]; peak post: 0.024 
[0.004–0.244] μg/L; p = 0.000), with substantial individual 
variability in peak values. PBA and JBA players showed 
higher baseline and post-exercise cTnI values than ABA 
(all p < 0.05). Peak cTnI exceeded the upper reference limit 
(URL) in the 26% of players (3 PBA; 6 JBA).
Conclusions: The current results suggest that intermittent 
exercise can promote the appearance of cTnI and that this 
is potentially mediated by athlete status.
Keywords: athlete status; biological age; cTnI; intermittent 
exercise.
Introduction
The release of biomarkers of cardiamyocyte insult during 
and after exercise, such as cardiac troponins (cTn), is 
the topic of intense scientific enquiry and debate [1, 2]. 
Evidence to date suggests a substantial number of ath-
letes exceed the upper reference limit (URL) of cTn after 
long- [1, 3] and short-duration endurance exercise [4], as 
well as after moderate- [5] and low-intensity continuous 
exercise [6].
Beyond description, several recent studies have 
attempted to determine what personal and exercise-
related factors may promote an increase in cTn after 
exercise. An elevation in cardiac troponin I (cTnI) 
has been associated with increased exercise duration 
and intensity [5], exercise mode [7]; training level [8] 
and biological age [9]. In many of these areas data is 
contradictory.
For example, available scientific data related to cTn 
release after intermittent exercise, such as soccer [10, 
11], rugby [12], basketball [13] or floorball [14] is limited, 
often poorly controlled [12] and with limited sampling 
times post-exercise [11, 12, 14]. Consequently this has 
produced contradictory data. Further it has been pro-
posed that less experienced endurance athletes are 
more likely to exhibit detectable cTn levels than more 
experienced athletes after exercise [8, 15–19]. These data 
are largely derived from field-base studies with limited 
post-exercise sample points in amateur runners that may 
underestimate peak cTn release [20]. The cTn release in 
professional elite athletes is less well understood with a 
few, older data sets also limited by sampling frequency 
[21, 22]. Unlike most of the previous results, we have 
recently observed in untrained subjects that a controlled 
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endurance training intervention resulted in higher pre- 
and post-exercise values of cTn [23]. Nevertheless, the 
influence of training level on cTn release has not yet 
been evaluated in a controlled study with disparate 
groups in terms of training or athletic status. Evidence to 
date also suggests increased cTn appearance after exer-
cise in adolescent athletes, possibly due to their imma-
ture cardiac muscle [9, 18, 19, 24, 25], although only Tian 
et al. [9] directly compared adult and adolescent athletes 
in a controlled study. Currently, it is unknown if the cTn 
response to intermittent exercise is similar in adults and 
adolescents.
In an attempt to resolve these issues we examined, 
employing multiple sampling points during 24  h recov-
ery from exertion, the influence of a simulated basketball 
match on the cTnI appearance in players with different 
status/training level (elite and amateur) as well as adult 
and adolescent basketball players. We hypothesise that 
cTnI appearance during recovery would be increased in 
adolescent and amateur players.
Materials and methods
Subjects and design
A total of 36 male basketball players (12 adult, elite, professional 
players from Spanish ACB League; [PBA], 12 adult, amateur players 
from a local league [ABA], and 12 elite junior players [Spanish Junior 
Top-Division; JBA]) were recruited and gave personal (and parental 
in JBA) written informed consent to participate in a simulated bas-
ketball match with serial assessment of cTnI during the first 24 h of 
recovery. The study was approved by the Research Ethics Commit-
tee of the Government of Aragón (Spain), and all players and their 
parents were informed of the purpose, nature, testing procedures, 
possible risks, and their right to terminate participation at will. The 
study complies with the principles laid down in the Declaration of 
Helsinki, adopted by the 18th World Medical Assembly, Helsinki, 
Finland, June 1964, and recently amended at the 59th World Medical 
Assembly, Seoul, Korea, October 2008.
The characteristics of the study population are shown in Table 1. 
PBA had higher training history and current training volume than 
both ABA and JBA (all p < 0.05). By design JBA were younger but there 
was no difference in age between PBA and ABA.
All subjects attended the laboratory on three occasions. At a pre-
liminary testing session, 1 week before the main study, body height 
was measured to the nearest 0.1  cm (SECA 225, SECA, Hamburg, 
 Germany) and body mass was determined to the nearest 0.05 kg (SECA 
861, SECA). A questionnaire was completed to obtain personal data, 
training history, and history of cardiac symptoms (if any). A 12-lead 
ECG was performed and exclusion criteria were significant cardiac his-
tory or pathological electrocardiograph. All players then performed 
the 20 m shuttle run test [26] with the objective to estimate VO2max and 
determine maximal heart rate (HR) using a Polar Team 2 system (1.4.1, 
Polar Electro Oy, Kempele, Finland).
Prior to the initial laboratory visit and the main train all play-
ers were instructed to avoid strenuous training for 48  h before the 
test and to maintain their normal diet, hydration, and sleep routine. 
Moreover, subjects ate their last meal at least 2 h before the test and 
were asked not to ingest any potentially ergogenic product (i.e. caf-
feine).
For the second laboratory visit every group was divided in two 
teams to perform the match, and the players played in their usual 
position. The matches followed the regulations established by the 
International Basketball Federation (FIBA). Every team made a 
change every 4 min of actual game time, so all players participated 
for the same amount of time (32 of the 40 min actual playing time). 
All players performed a similar warm-up and treated the match as a 
normal competitive game. Strong and standardized verbal encour-
agement was offered during the matches to achieve and intensity of 
play similar to competition. HR was recorded continuously during 
the basketball match using a Polar Team 2 system (1.4.1, Polar Electro 
Oy). The matches began at 11.30 am and took place in an indoor bas-
ketball field at a temperature of 20 °C and relative humidity of 60%. 
Venous blood samples were taken before, immediately after (5 min), 
and 1, 3, 6, 12 h after exercise to assess serum cTnI. A final laboratory 
visit occurred the following day to collect a 24 h post-exercise blood 
sample.
Blood samples were drawn from an antecubital vein and quickly 
centrifuged. Serum and plasma were drawn off and stored at −80 °C 
for later analysis. cTnI was analyzed from samples of EDTA plasma 
with the Access AccuTnI assay (Beckman Coulter, Fullerton, CA, 
USA). The imprecision profile of 839 duplicate samples showed 10% 
and 20% coefficient of variation values of 0.014 and 0.008 μg/L, 
respectively. The URL for cTnI, defined as the 99th percentile of 
healthy participants, was 0.04 μg/L [27].
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Table 1: Characteristics of the basketball cohorts. 
  Age, years  Body mass, kg  Height, cm  VO2max, mL/kg/min  Basketball 
training 
history, 
years
  Basketball 
training 
frequency, 
sessions/week
  Basketball 
training 
volume, 
h/week
Adult elite (PBA; n = 12)   27.3±4.1c  98.3±12.9a,c  199±7a,c  58±3  17±5a,c  6±0a,c  16±0a,c
Adult amateur (ABA; n = 12)  29.6±2.9b  83.8±12.9  184±6b  56±7  13±3b  4±1  8±4
Junior elite (JBA; n = 11)   16.6±0.9  82.8±10.3  192±8  58±3  8±4  4±0  8±0
Data are mean±SD. aSignificant difference between PBA and ABA basketball players. bSignificant difference between ABA and JBA basket-
ball players. cSignificant difference between PBA and JBA basketball players.
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Statistical analysis
Statistical analyses were performed using the IBM Statistical Pack-
age of Social Sciences (IBM SPSS Statistics, v. 20.0 for WINDOWS). 
Data are expressed as the mean±SD unless otherwise stated. Kolmog-
orov-Smirnov tests were used to analyze for normal distribution and 
consequently cTnI data were log-transformed prior to inferential sta-
tistical testing. To measure the impact of sampling time during recov-
ery (pre, 5 min, 1, 3, 6, 12, and 24 h post-exercise) and athletes status 
(PBA vs. ABA vs. JBA) upon cTnI, a mixed model two-way ANOVA 
were performed with post-hoc Bonferroni tests employed when 
appropriate. The association between an increase in cTnI (the differ-
ence between baseline and peak post-exercise value) and other rele-
vant variables (e.g. baseline cTnI, mean and max exercise HR during 
simulated basketball play) were assessed using bivariate Pearson’s 
product moment correlation coefficients in the entire study cohort. 
The values were considered to be significant if p < 0.05.
Results
The HRmax attained during the 20 m shuttle run was not 
different between groups. The mean HR and % HRmax 
during the match was lower in PBA compared to ABA and 
JBA (Table 2).
In the junior basketball match one player was injured 
and replaced. This subject was excluded from final data 
analysis. A significant main effect of sampling time was 
observed for cTnI with increases, compared to pre-exer-
cise, at 1-, 3-, 6-, 12-, and 24-h post-exercise (p = 0.000) 
(Figure  1). A significant main effect of group was noted 
with both baseline and recovery cTnI lower in ABA when 
compared to both PBA and JBA (p = 0.001). In support of 
this there were differences between groups in the peak 
post-exercise values of cTnI (ABA: median [range]; 0.015 
[0.004–0.039]; PBA: 0.027 [0.007–0.244]; JBA: 0.041 
[0.012–0.208] μg/L; p = 0.011). There was no significant 
group by time interaction term (p = 0.174).
Compared with the basal levels, increased post-
effort cTnI values were observed in all individuals. 
Despite this, individual variability in peak cTnI was 
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Figure 1: Individual data points for cTnI (μg/L) in adult elite (PBA; 
n = 12) (A), adult amateur (ABA; n = 12) (B) and junior elite (JBA; n = 11) 
(C) basketball players at pre-exercise (PRE), as well as 5 min, 1, 3, 6, 
12, and 24 h (0HR, 1HR, 3HR, 6HR, 12HR, 24HR, respectively).
The horizontal dotted line is the upper reference limit (99th percen-
tile) at 0.04 μg/L.
Table 2: Heart rate during the basketball match. 
  Mean HR, 
beats/min %
  HRmax, %
PBA (n = 12)  150±11a,b  79±4a,b
ABA (n = 12)  168±9  87±3
JBA (n = 11)   167±10  84±4
Data are mean±SD. aSignificant difference between PBA and ABA 
basketball players.  bSignificant difference between PBA and JBA 
basketball players.
noted with 26% of players (3 PBA and 6 JBA) exceed-
ing the URL of cTnI (Figure 1). The maximum post-effort 
value was observed at 1 h in two individuals, 3 h in two 
individuals, 6 h in 23 individuals, 12 h in five individu-
als, and 24 h in two individuals suggesting a degree of 
heterogeneity in cTnI appearance “kinetics”. It is also 
pertinent to note one JBA had an elevated cTnI at 24 h 
post-exercise.
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Peak post-exercise values of cTnI was not associated 
with player position, mean HR or % HRmax, but was associ-
ated with baseline values (r = 0.54, p = 0.001).
Discussion
This is the first study to investigate post-exercise cTnI 
“kinetics” after intermittent exercise performed in a 
controlled environment in distinct groups of athletes 
differentiated by athlete status and biological age. The 
key findings from our study are; 1) intermittent exercise 
resulted in a cTnI change in all athletes although the mag-
nitude of response was heterogeneous; 2) the baseline 
and post-exercise cTnI was lowest in ABA compared to 
PBA and JBA; and 3) the cTnI response post-exercise was 
similar in elite adult and junior basketball players.
Previous studies documenting cTn release during 
intermittent exercise have reported contradictory results. 
A plausible explanation for this contradictory evidence 
has been the limited and varied number of biomarker 
sampling points employed in past studies. Whilst the 
current study observed an increased in cTnI post-exercise 
in all participants this runs contrary to both George et al. 
[12] and Rahnama et al. [11] who did not observe any cTnI 
increase. The likely explanation for this discrepancy was 
the use of a simple pre-post exercise sampling regime in 
previous work. The current data supports Nie et al. [13], 
in basketball players, and Carranza-García et  al. [10], in 
futsal players, who reported an increase in cTn several 
hours after simulated match. Consequently, our find-
ings show, in line with continuous endurance exercise 
studies [4, 20], the importance of obtained multiple blood 
samples during recovery to observe the maximum post-
effort value.
Individual heterogeneity of peak cTnI was observed 
with 26% of the players presenting with one cTnI value 
over the URL. This percentage is lower than reported after 
endurance events, such as marathon [7] or cycling [3], and 
the more modest changes in the current study likely reflect 
the low total exercise duration and volume compared to 
many previous endurance and ultra-endurance activities 
[7]. Previous studies have noted that the increase in cTnI 
or cTnT is mainly mediated by the exercise duration when 
the intensity is controlled [5, 28].
Our results support heterogeneity in peak cTnI 
appearance and analysis of time to peak cTnI suggest 
some degree of variance in the pattern or “kinetics” of 
cTnI appearance, although it is noted that all partici-
pants, bar one JBA, demonstrated a return to baseline 
levels at the 24 h assessment point. The one JBA with an 
elevated (above URL) cTnI at 24 h post-exercise was sign- 
and symptom-free and unremarkable in personal or exer-
cise details. Several studies have suggested a single blood 
sample 3–4 h post-exercise will reflect cTn peak post-exer-
cise [18, 24, 29]. Our results are somewhat different with 
the most common time for cTnI peak at 6 h post-exercise. 
These data suggest that time when the peak post-exercise 
value may be dependent upon exercise mode, duration 
and/or intensity and further work is required.
The pattern of cTn appearance and clearance post-
exercise runs contrary to changes in cTn observed in acute 
coronary syndromes. This suggests that post-exercise cTn 
levels may be related to a physiological rather than a path-
ological response after the exercise stimulus. The hypoth-
esis has been stated that endurance exercise causes an 
increase in membrane permeability due to the physiologi-
cal stress placed on the cell, inducing a transient cytosolic 
leakage due to membrane damage, rather than cardiomy-
ocyte necrosis [2].
Recently, some studies have suggested that cTn release 
after exercise may be more pronounced in less trained 
subjects [8, 15–19] as a consequence of a lower myocardial 
work efficiency. Thus, cTn release during exercise in those 
with lower training levels or athlete status could be one 
consequence of the adaptive process in myocardial cells, 
similarly to the process observed in skeletal muscle, which 
protects them against future bouts of strenuous exercise 
[15, 16]. Our results did not support this theory with PBA 
and JBA demonstrating greater post-exercise values than 
ABA, even when PBA achieved a slightly lower mean HR 
and % HRmax during the simulated game. These data are 
consistent with our recent controlled endurance training 
intervention [23] and a field-based study with maratho-
ners [30].
The higher post-exercise cTnI values in PBA and 
JBA than ABA were associated with differences in base-
line cTnI. The association between baseline and post-
exercise cTnI values have been previously reported [5, 
31, 32]. In healthy population little attention has been 
focused to the variability of baseline cTn values. Mingels 
et al. [17] obtained significantly higher hs-cTnT in males 
than in females. The authors speculated that these dif-
ferences were as a consequence of the heart size of men 
being larger than women. The same explanation could 
be used to justify the higher baseline and post-exercise 
cTnI values our PBA players (adults), because the size of 
heart is greater in athletes with higher performance [33, 
34], although it is not clear if heart size is different in JBA 
when compared to older ABA. Recent work from Saravia 
et  al. [30] has suggested a link between higher levels 
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of inflammation and increased cTn in faster marathon 
runners. Further research into the factors associated with 
the inter-subject variability in the baseline and exercise-
related values of cTn are required.
The lack of differences between PBA and JBA players 
may indicate that biological age does not mediate signifi-
cant differences in the cTn response to intermittent exer-
cise in elite athletes. Some caution should be expressed in 
this comment based on the small, but statistically signifi-
cant, differences in CV work undertaken during exercise in 
PBA when compared to JBA as well as that if you compare 
JBA to ABA (still a biological age comparison with similar 
weekly training volumes) then a difference is noted with 
JBA exhibiting a larger response than older ABA. This 
comparison compares more favorably to past work assess-
ing the impact of biological age on post-exercise cTn 
appearance [18, 19, 24, 25]. The complex interaction here 
of biological age, training volume and elite athlete status 
is complex to “un-pick” and requires further work.
Clinicians should be aware that the release of cTnI is 
not exclusive to long-term strenuous efforts. cTnI values 
above the URL can be observed after intermittent exercise, 
such as basketball match, with heterogeneity noted in 
peak and kinetic data. From a clinical perspective, there is 
a limited rationale for full cardiovascular examination all 
athletes with positive cTn concentrations in the absence of 
other clinical signs and symptoms. When evaluating cTn 
in an emergency setting, detailed information regarding 
any recent exercise activities should be obtained, espe-
cially in the first 24 h post-exercise.
In addition to comments above we note the inherent 
limitation of cross-sectional studies in that the observed 
differences in the values of cTnI between PBA and ABA 
may have resulted from differences other personal factors 
(e.g. genetic differences) as well as exposure to different 
training volumes. To resolve this issue it would be inter-
esting to observe the impact of a training program on exer-
cise-induced cardiac biomarker release.
In this study, we highlighted that intermittent high-
intensity exercise, as basketball match, resulted in a 
cTnI change in all athletes although the magnitude of 
response was heterogeneous. In addition, our results 
did not support the hypothesis of previous studies sug-
gesting that cTnI release after exercise may be more pro-
nounced in less trained subjects [8]. We also observed 
that the pattern of cTnI appearance and clearance post-
exercise runs contrary to changes in cTn observed in acute 
coronary syndromes. This suggests that post-exercise cTn 
levels may be related to a physiological rather than a path-
ological response after the exercise stimulus. Finally, this 
investigation prompts further research into the factors 
associated with the inter-subject variability in the base-
line and exercise-related values of cTnI.
Conclusions
Our results show that intermittent exercise, in this case 
a simulated basketball match, resulted in an increase 
in post-exercise cTnI in all athletes with a varied peak 
and time-to-peak cTnI. The second key finding was that 
athlete status mediated cTn appearance with elite athletes 
presenting with higher values than amateur athletes.
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